Health Cor Management, L.P. Biotechnology

Health Cor Management, L.P.

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
BMRN Biomarin Pharmaceutical Inc	$12.5B	$38.1 Million 35.97% of portfolio	367,765	Q4 2022 Reduced 51.55%
CYTK Cytokinetics Inc	$5.46B	$7.53 Million 7.12% of portfolio	164,440	Q4 2022 Reduced 62.16%
SNDX Syndax Pharmaceuticals Inc	$1.23B	$1.78 Million 1.68% of portfolio	70,000	Q4 2022 Reduced 91.85%
KDNY Chinook Therapeutics, Inc.	$0	$1.57 Million 1.49% of portfolio	60,000	Q4 2022 Reduced 77.51%
BPMC Blueprint Medicines Corp	$6.02B	$1.31 Million 1.24% of portfolio	30,000	Q4 2022 Reduced 71.32%
GERN Geron Corp	$1.61B	$1.21 Million 1.14% of portfolio	500,000	Q4 2022 Reduced 73.74%
RCKT Rocket Pharmaceuticals, Inc.	$1.32B	$978,000 0.92% of portfolio	50,000	Q4 2022 Reduced 88.77%
RAIN Rain Therapeutics Inc.	$0	$960,000 0.91% of portfolio	120,000	Q4 2022 New
IMGN Immuno Gen, Inc.	$0	$744,000 0.7% of portfolio	150,000	Q4 2022 Reduced 88.46%

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.